HbA1c: what your result means.

HbA1c (glycated haemoglobin) reflects your average blood glucose over the previous ~three months, measured as the percentage of haemoglobin with glucose attached. It is the cornerstone marker for diagnosing prediabetes and diabetes.

Why HbA1c matters

Glucose dysregulation damages vessels years before diabetes is diagnosed. HbA1c catches the drift early: ADA thresholds define 5.7–6.4% as prediabetes, a stage where progression is still highly reversible through diet, exercise and weight change.

Associated risks when out of range: Diabetes risk. Cardiovascular disease. Cognitive decline risk.

What the clinical evidence shows

The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets HbA1c, from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.

• Diabetes Prevention Program (Knowler et al. NEJM 2002): in adults with prediabetes, structured lifestyle change cut progression to type 2 diabetes by 58%, nearly double the effect of metformin (31%), the strongest evidence that the prediabetic window is reversible.
• UKPDS 35 (Stratton et al. BMJ 2000): each 1% reduction in HbA1c was associated with ~14% fewer myocardial infarctions and ~37% less microvascular disease, with no threshold below which lower HbA1c stopped helping.
• ARIC analysis (Selvin et al. NEJM 2010): in adults without diabetes, HbA1c predicted cardiovascular disease and death better than fasting glucose. Elevated-normal HbA1c carries risk long before any diagnosis.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets HbA1c against published clinical authority standards, never arbitrary "optimal" ranges. Measured in %:

Clinical interpretation

• Reflects average glucose over 2–3 months; not affected by acute stress or single meals.
• Can be falsely low in haemolytic conditions or high RBC turnover; falsely high in iron deficiency.
• Observational longevity target: some preventive medicine literature suggests HbA1c <5.4% is associated with maximal healthspan, but ADA does not endorse this as a formal target for the general population. This is an internal optimisation preference, not a guideline-endorsed diagnostic band.

What improves it: the evidence-based levers

• Improve insulin sensitivity
• Weight reduction
• Exercise
• Reduce refined carbs

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How HbA1c testing works at HodieLabs

HbA1c is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (Diabetes Prevention Program). N Engl J Med. 2002;346:393–403.
2. Stratton IM, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ. 2000;321:405–412.
3. Selvin E, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800–811.
4. American Diabetes Association. Standards of Care in Diabetes. Classification and diagnosis of diabetes. Diabetes Care (updated annually).

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.